Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group
Robyn M. Scherber(Blueprint Medicines (United States)), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Jean‐Jacques Kiladjian(Délégation Paris 5), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), Heike L. Pahl(University Medical Center Freiburg), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Andreas Reiter(Heidelberg University), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Harry C. Schouten, Heidi Kosiorek(Mayo Clinic in Florida), Jean‐Yves Cahn, Konstanze Doehner(University Hospital Ulm), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Jan Samuelsson(Karolinska University Hospital), Peter Johansson(Linköping University), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Holly L. Geyer(Mayo Clinic Hospital), Peter A.W. te Boekhorst(Erasmus MC), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tiziano Barbui(University of Bergamo), Gabriel Étienne(Institut Bergonié), Maria L Ferarri(Centre Hospitalier Universitaire de Grenoble), Suzan Commandeur(Leiden University), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Sonja Zweegman(Vrije Universiteit Amsterdam), K. Bonatz(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), Zefeng Xu(Henan University), Peihong Zhang(Tongji University), Junqing Xu(Shenzhen University), Norman I Maldonado(University of Puerto Rico System), Keith Cannon(Mayo Clinic in Arizona), Françoise Boyer(Centre Hospitalier Universitaire d'Angers), Ana Kerguelen Fuentes(Centre Hospitalier Universitaire de Grenoble), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Xuijuan Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Lydia Roy(Centre Hospitalier Universitaire de Poitiers)
Cited by 5
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k